← Back to Search

CKM Jumpstart Tool for Chronic Kidney Disease

N/A
Recruiting
Led By Susan P Wong, MD, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is testing a tool to help older patients with advanced kidney disease and their healthcare providers talk about conservative kidney management.

Who is the study for?
This trial is for English-speaking adults aged 75 or older with advanced chronic kidney disease (CKD), defined by specific low eGFR levels. Participants must receive care from UW Medicine or VA Puget Sound and be open to discussing treatment options. Those already on maintenance dialysis, or unable to consent are excluded.Check my eligibility
What is being tested?
The study is testing the CKM JumpStart Tool's effectiveness in facilitating conversations between elderly patients with advanced CKD and their healthcare providers about conservative kidney management.See study design
What are the potential side effects?
Since this trial involves a discussion tool rather than a medical intervention, traditional physical side effects are not expected. However, participants may experience emotional discomfort during discussions about their condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attrition
Patient-provider discussion of CKM
Secondary outcome measures
Documentation of CKM Discussion
Patient Post-Intervention Interview
Provider Use of CKM Jumpstart Tool
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CKM Jumpstart ToolExperimental Treatment1 Intervention
Receives intervention
Group II: ControlActive Control1 Intervention
Does not receive intervention

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,684 Total Patients Enrolled
Susan P Wong, MD, MSPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants who are being recruited for this research study?

"Affirmative. The information on clinicaltrials.gov states that this research endeavor is actively seeking participants. It was first made public on April 10, 2023, and the most recent update occurred on March 30, 2024. A total of 76 patients are sought from two designated locations."

Answered by AI

Are patients currently able to enroll in this ongoing medical study?

"Yes, the details available on clinicaltrials.gov confirm that this research endeavor is actively seeking volunteers. The study was first listed on April 10th, 2023 and last modified on March 30th, 2024. It aims to enroll a total of 76 participants from two distinct locations."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Pilot Study of The CKM JumpStart Tool
Susan Wong 2023. "A Pilot Study of The CKM JumpStart Tool". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05753020.
~30 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top